{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:15:51Z","timestamp":1648926951740},"reference-count":29,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.8762","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T12:27:13Z","timestamp":1526905633000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of decoy receptor 3 upregulation in patients with hepatitis B and liver fibrosis"],"prefix":"10.3892","author":[{"given":"Xiaoli","family":"Lou","sequence":"first","affiliation":[{"name":"Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiang","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"key20200714082845_b1-ol-0-0-8762","first-page":"3","article-title":"Management of hepatitis B in China","volume":"122","author":"Lu","year":"2009","journal-title":"Chin Med J (EngI)"},{"key":"key20200714082845_b2-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"EpidemioIogicaI serosurvey of hepatitis B in China-decIining HBV prevaIence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"key20200714082845_b3-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"key20200714082845_b4-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11596-015-1416-3","article-title":"Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses","volume":"35","author":"Meng","year":"2015","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20200714082845_b5-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.clinbiochem.2015.07.019","article-title":"Hyaluronic acid as a non-invasive biomarker of liver fibrosis","volume":"49","author":"Neuman","year":"2016","journal-title":"Clin Biochem"},{"key":"key20200714082845_b6-ol-0-0-8762","first-page":"344","article-title":"The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology","volume":"20","author":"Jiang","year":"2012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20200714082845_b7-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40199-015-0135-4","article-title":"Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats","volume":"23","author":"You","year":"2015","journal-title":"Daru"},{"key":"key20200714082845_b8-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1097\/MD.0000000000001889","article-title":"Can Serum ST2 levels be used as a marker of fibrosis in chronic Hepatitis B infection?","volume":"94","author":"Oztas","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key20200714082845_b9-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"e0152757","DOI":"10.1371\/journal.pone.0152757","article-title":"The diagnostic accuracy and clinical utility of three noninvasive models for predicting liver fibrosis in patients with HBV Infection","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"key20200714082845_b10-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/hep.21738","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"key20200714082845_b11-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cca.2012.01.007","article-title":"Serum decoy receptor 3, a potential new biomarker for sepsis","volume":"413","author":"Hou","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key20200714082845_b12-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"e0131680","DOI":"10.1371\/journal.pone.0131680","article-title":"Decoy receptor 3 improves survival in experimental sepsis by suppressing the inflammatory response and lymphocyte apoptosis","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"key20200714082845_b13-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/COH.0000000000000370","article-title":"Diagnosis of viral hepatitis","volume":"12","author":"Easterbrook","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"key20200714082845_b14-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.bbadis.2018.01.009","article-title":"Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future goldstandard?","volume":"1864","author":"Lambrecht","year":"2018","journal-title":"Biochim Biophys Acta."},{"key":"key20200714082845_b15-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3348\/kjr.2016.17.3.396","article-title":"Liver shear-wave velocity and serum fibrosis markers to diagnosis hepatic fibrosis in patients with chronic vial Hepatitis B","volume":"17","author":"Liu","year":"2016","journal-title":"Korean J Radiol"},{"key":"key20200714082845_b16-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3350\/cmh.2014.20.4.347","article-title":"Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B","volume":"20","author":"Cho","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"key20200714082845_b17-ol-0-0-8762","first-page":"302","article-title":"The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis","volume":"77","author":"Alempijevi\u0107","year":"2014","journal-title":"Acta Gastroenterol Belg"},{"key":"key20200714082845_b18-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bcp.2011.01.011","article-title":"Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmube diseases and cancer","volume":"81","author":"Lin","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20200714082845_b19-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2015.02.007","article-title":"The TL1A\/DR3\/DcR3 pathway in autoimmune rheumatic diseases","volume":"45","author":"Siakavellas","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"key20200714082845_b20-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.dld.2008.11.019","article-title":"Significance of increased expression of decoy receptor 3 in chronic liver disease","volume":"41","author":"Kim","year":"2009","journal-title":"Dig Liver Dis"},{"key":"key20200714082845_b21-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.clim.2010.07.001","article-title":"High intestinal and systemic levels of decoy receptor 3 (DcR3)and its ligand TL1A in active ulcerative colitis","volume":"137","author":"Bamias","year":"2010","journal-title":"Chin Immunol"},{"key":"key20200714082845_b22-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1620\/tjem.230.227","article-title":"Serum decoy receptor 3 is a useful predictor for the active status of chronic hepatitis B in hepatitis B e antigen-negative patients","volume":"230","author":"Hou","year":"2013","journal-title":"Tohoku J Exp Med"},{"key":"key20200714082845_b23-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/03009734.2010.516410","article-title":"Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients","volume":"115","author":"Yang","year":"2010","journal-title":"Ups J Med Sci"},{"key":"key20200714082845_b24-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000323522","article-title":"Expression of DcR3 and its effects in kaposi's sarcoma-associated herpesvirus-infected human endothelial cells","volume":"55","author":"Yoo","year":"2012","journal-title":"Intervirology"},{"key":"key20200714082845_b25-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1600-0625.2011.01304.x","article-title":"Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions","volume":"20","author":"Bamias","year":"2011","journal-title":"Exp Dermatol"},{"key":"key20200714082845_b26-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-017-0347-7","article-title":"Decoy receptor 3: An endogenous immubomudulator in cancer growth and inflammatory reactions","volume":"24","author":"Hsieh","year":"2017","journal-title":"J Biomed Sci"},{"key":"key20200714082845_b27-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1128\/JVI.02448-06","article-title":"Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter","volume":"81","author":"Ho","year":"2007","journal-title":"J Virol"},{"key":"key20200714082845_b28-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/carcin\/bgp135","article-title":"Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion","volume":"30","author":"Ho","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20200714082845_b29-ol-0-0-8762","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4049\/jimmunol.1101652","article-title":"Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx\/ERK\/NF-\u03baB pathway","volume":"188","author":"Xia","year":"2012","journal-title":"J Immunol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T08:49:19Z","timestamp":1594716559000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.8762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":29,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.8762","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]}}}